J&J ETFs to Gain on Upbeat COVID-19 Vaccine Data

The positive data update has put the spotlight on a number of ETFs that could benefit from their high exposure to Johnson & Johnson.

Leave a Reply

Your email address will not be published. Required fields are marked *